365 WMG Private Fund I: Primus Fund LLC’s Elevance Health ELV Stock Holding History

365 WMG Private Fund I: Primus Fund LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$930K	Buy	+2,393	New	+$955K	0.55%	51

Other funds holding ELV

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

365 WMG Private Fund I: Primus Fund LLC's ELV Position: Q3 2026 in Review

365 WMG Private Fund I: Primus Fund LLC opened a new position in Elevance Health (ELV) in Q3 2026: 2,393 shares worth $930K. The stake represents 0.55% of the portfolio and ranks #51 among its holdings.

299 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

365 WMG Private Fund I: Primus Fund LLC held 2,393 shares of Elevance Health worth $930K as of Q3 2026.
Elevance Health was a new 365 WMG Private Fund I: Primus Fund LLC position in Q3 2026.
Elevance Health made up 0.55% of 365 WMG Private Fund I: Primus Fund LLC's portfolio in Q3 2026, its #51 holding.
299 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on 365 WMG Private Fund I: Primus Fund LLC's 13F filing for Q3 2026, filed 20 Oct 2026.